Please use this identifier to cite or link to this item:
|Title:||Clinical outcomes after arteriovenous fistula creation in chronic kidney disease.||Austin Authors:||Lee, Mardiana ;Roberts, Matthew A;Smith, Maree-Ross;Chuen, Jason ;Mount, Peter F||Affiliation:||Department of Nephrology, Austin Health, Heidelberg, Victoria, Australia||Issue Date:||26-Apr-2014||Publication information:||Blood Purification 2014; 37(3): 163-71||Abstract:||Optimal timing of arteriovenous fistula (AVF) surgery in chronic kidney disease (CKD) is uncertain.A single-centre retrospective study of pre-dialysis CKD patients having first AVF surgery.The median estimated glomerular filtration rate (eGFR) at the time of AVF surgery in 100 patients was 15 ml/min/1.73 m(2), with patients classified as having an early AVF if eGFR was >15 ml/min/1.73 m(2) (n = 46) or a late AVF if eGFR was ≤15 ml/min/1.73 m(2) (n = 54). In the eGFR ≤15 group, 81% of patients started haemodialysis (HD), compared with 63% of the eGFR >15 patients (p = 0.04). The median time to starting HD was 30.3 months in the eGFR >15 group compared to 10.7 months for the eGFR ≤15 group (log rank p = 0.018). There were no differences in the requirements for a dialysis catheter (eGFR >15 24% vs. eGFR ≤15 11%, p = 0.20) or additional access procedures between the two groups.AVF surgery with an eGFR >15 ml/min/1.73 m(2) was associated with a higher risk of AVF non-use and a more prolonged time to the need for HD.||Gov't Doc #:||24777074||URI:||http://ahro.austin.org.au/austinjspui/handle/1/12195||DOI:||10.1159/000360273||Journal:||Blood Purification||URL:||https://pubmed.ncbi.nlm.nih.gov/24777074||Type:||Journal Article||Subjects:||Aged
Arteriovenous Shunt, Surgical.methods
Renal Insufficiency, Chronic.therapy
|Appears in Collections:||Journal articles|
Show full item record
checked on Feb 3, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.